HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.
Hybrid Vigor in Crops
Hybrid Vigor in Crops
Hybrid vigor, or heterosis, is the phenomenon where hybrid offspring exhibit superior qualities compared to their parents, such as increased yield, disease resistance, and growth rate. Hybrid vigor results from the combination of diverse alleles, which leads to enhanced genetic expression. In agriculture, hybrid crops are bred to maximize desired traits, resulting in plants that are more productive and resilient to stress. Hybrid vigor is particularly valuable in staple crops like maize, rice, and wheat, where it has significantly boosted yields. This approach is crucial in meeting food demands, as hybrid crops often require fewer resources while providing greater outputs.
Committee Members
Srinivasa Rao Mentreddy
Alabama A&M University, United States
Mohammad Babadoost
University of Illinois, United States
Valasia Iakovoglou
UNESCO chair Con-E-Ect, International Hellenic University, Greece GPB 2027 Speakers
Aparna B Gunjal
Dr. D.Y. Patil, Arts, Commerce and Science College, India
Anna Ponce
Bethune-Cookman University, United States
Hillary Jean Pierre
Department of Pharmaceutics, United States
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States